ISIS-333611

DB17978ExperimentalGene Therapies

ISIS-333611: Overview.

Resolves to

Compound
UNII5QY760I44WCAS937407-37-9

Which companies are running trials of ISIS-333611, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In